US SEC Trading Suspension Halt Orders — October 02, 2026
This digest covers 8 regulatory filings from October 2, 2026, all involving trading suspensions or delistings on US exchanges (NYSE American and Nasdaq). The dominant theme is a wave of micro-cap and pre-revenue companies failing to maintain minimum bid price or market value standards, with 6 of 8 filings triggered by sub-$1.00 bid prices. Notably, Healthcare Triangle faces an expedited delisting due to two reverse stock splits in two years, while Direct Digital Holdings and Amaze Holdings have already received final delisting notices with no appeal. The cluster of filings on September 28-29, 2026, suggests a coordinated exchange compliance review. No period-over-period financial data, insider activity, or capital allocation metrics were available in these filings, limiting quantitative trend analysis. The materiality is uniformly high (8-10/10), as delisting from a major exchange to OTC Pink or similar severely impairs liquidity and capital access. The key forward-looking dates cluster around March 29, 2027, for compliance deadlines, creating a catalyst calendar for investors to monitor.